1.Comparison of Training Effectiveness for IV Injections: Intravenous (IV) Arm Model versus Computer Simulator.
Journal of Korean Academy of Fundamental Nursing 2014;21(3):302-310
PURPOSE: The purpose of this study was to compare the effectiveness of training using an intravenous (IV) arm model versus a computer simulator for IV injections. METHOD: Study was a quasi-experimental study conducted with 106 nursing students. Participants were divided into two groups: the IV Arm Group using a mannequin arm model (control group) and the Computer Simulator Group using the Virtual IV demonstration (experimental group). Theoretical lectures and video presentations on IV injections were given to both groups. Each group went through the training practice using the IV arm or computer simulator. After the completion of training, questionnaires were given to the students to evaluate their learning attitudes and experiences, self-confidence in IV injection, and satisfaction with the training materials. RESULTS: Student satisfaction with the training materials including the reality, usefulness, and educational effects showed notable differences between the two groups with the Computer Simulator group reporting more positive effects that the IV Arm group. However, there was no statistical difference between the two groups in the categories of learning attitude, learning experience, or self-confidence. CONCLUSION: While there was a differences in strengths and weaknesses of the two methods, both methods should be considered for practice and further study needs to be done on educational effectiveness.
Arm*
;
Computer Simulation
;
Humans
;
Injections, Intravenous
;
Learning
;
Lectures
;
Manikins
;
Surveys and Questionnaires
;
Students, Nursing
2.Behavioral and Healthcare-Associated Risk Factors for Chronic Hepatitis C Virus Infection in Korea.
Jong Yeop KIM ; Juhee CHO ; Sung Ho HWANG ; Ho KIL ; Si Hyun BAE ; Young Seok KIM ; Han Chu LEE ; Sook Hyang JEONG
Journal of Korean Medical Science 2012;27(11):1371-1377
The risk factors related to hepatitis C virus (HCV) infection showed geographic and temporal differences. We investigated HCV-related risk factors in Korea where intravenous drug use (IVDU) is uncommon. The HCV-related risk factors were investigated in a prospective, multicenter chronic HCV cohort (n = 711) using a standardized questionnaire in four university hospitals. The results were compared with those of 206 patients with chronic liver diseases not related to either of HCV or hepatitis B virus infection (comparison group). The IVDU was found in 3.9% and remote blood transfusion (> or = 20 yr ago) in 18.3% in HCV cohort group, while that in comparison group was in none and 5.3%, respectively. In a multivariate logistic analysis, transfusion in the remote past (odds ratio [OR], 2.99), needle stick injury (OR, 4.72), surgery (OR, 1.89), dental procedures (OR, 2.96), tattooing (OR, 2.07), and multiple sexual partners (2-3 persons; OR, 2.14, > or = 4 persons; OR, 3.19), were independent risk factors for HCV infection. In conclusion, the major risk factors for HCV infection in Korea are mostly related to conventional or alterative healthcare procedures such as blood transfusion in the remote past, needle stick injury, surgery, dental procedure, and tattooing although multiple sex partners or IVDU plays a minor role.
Adult
;
Aged
;
*Attitude to Health
;
Blood Transfusion
;
Case-Control Studies
;
Cohort Studies
;
Female
;
*Health Behavior
;
Hepatitis C, Chronic/*etiology
;
Hospitals, University
;
Humans
;
Injections, Intravenous
;
Logistic Models
;
Male
;
Middle Aged
;
Needlestick Injuries/complications
;
Odds Ratio
;
Prospective Studies
;
Questionnaires
;
Republic of Korea
;
Risk Factors
;
Sexual Partners
;
Tattooing
;
Tooth Diseases/complications
3.Behavioral and Healthcare-Associated Risk Factors for Chronic Hepatitis C Virus Infection in Korea.
Jong Yeop KIM ; Juhee CHO ; Sung Ho HWANG ; Ho KIL ; Si Hyun BAE ; Young Seok KIM ; Han Chu LEE ; Sook Hyang JEONG
Journal of Korean Medical Science 2012;27(11):1371-1377
The risk factors related to hepatitis C virus (HCV) infection showed geographic and temporal differences. We investigated HCV-related risk factors in Korea where intravenous drug use (IVDU) is uncommon. The HCV-related risk factors were investigated in a prospective, multicenter chronic HCV cohort (n = 711) using a standardized questionnaire in four university hospitals. The results were compared with those of 206 patients with chronic liver diseases not related to either of HCV or hepatitis B virus infection (comparison group). The IVDU was found in 3.9% and remote blood transfusion (> or = 20 yr ago) in 18.3% in HCV cohort group, while that in comparison group was in none and 5.3%, respectively. In a multivariate logistic analysis, transfusion in the remote past (odds ratio [OR], 2.99), needle stick injury (OR, 4.72), surgery (OR, 1.89), dental procedures (OR, 2.96), tattooing (OR, 2.07), and multiple sexual partners (2-3 persons; OR, 2.14, > or = 4 persons; OR, 3.19), were independent risk factors for HCV infection. In conclusion, the major risk factors for HCV infection in Korea are mostly related to conventional or alterative healthcare procedures such as blood transfusion in the remote past, needle stick injury, surgery, dental procedure, and tattooing although multiple sex partners or IVDU plays a minor role.
Adult
;
Aged
;
*Attitude to Health
;
Blood Transfusion
;
Case-Control Studies
;
Cohort Studies
;
Female
;
*Health Behavior
;
Hepatitis C, Chronic/*etiology
;
Hospitals, University
;
Humans
;
Injections, Intravenous
;
Logistic Models
;
Male
;
Middle Aged
;
Needlestick Injuries/complications
;
Odds Ratio
;
Prospective Studies
;
Questionnaires
;
Republic of Korea
;
Risk Factors
;
Sexual Partners
;
Tattooing
;
Tooth Diseases/complications
4.Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
Minha HONG ; Seung Yup LEE ; Juhee HAN ; Jin Cheol PARK ; Yeon Jung LEE ; Ram HWANGBO ; Hyejung CHANG ; Seong Woo CHO ; Soo Young BHANG ; Bongseog KIM ; Jun Won HWANG ; Geon Ho BAHN
Journal of Korean Medical Science 2017;32(10):1687-1693
Children with autism are often medicated to manage emotional and behavioral symptoms; yet, data on such pharmacotherapy is insufficient. In this study, we investigated the Korean National Health Insurance Claims Database (NHICD) information related to autism incidence and psychotropic medication use. From the 2010–2012 NHICD, we selected a total of 31,919,732 subjects under 19 years old. To examine the diagnostic incidence, we selected patients who had at least one medical claim containing an 10th revision of International Statistical Classification of Diseases and Related Health Problems (ICD-10) code for pervasive developmental disorder, F84, not diagnosed in the previous 360 days. Psychotropics were categorized into seven classes. Then, we analyzed the data to determine the mean annual diagnostic incidence and psychotropic prescription trends. Diagnostic incidence was 17,606 for the 3 years, with a mean annual incidence per 10,000 population of 5.52. Among them, 5,348 patients were prescribed psychotropics. Atypical antipsychotics were the most commonly used, followed by antidepressants. An older age, male sex, and the availability of medical aid were associated with a higher rate of prescription than observed for a younger age, female sex, and the availability of health insurance. Psychotropic drugs were used for less than one-third of patients newly diagnosed with autism, and prescription differed by sex and age. Increased diagnostic incidence is associated with an increased prescription of psychotropic drugs. Therefore, medication-related safety data and policies for psychotropic drugs in autism should be prepared.
Adolescent*
;
Antidepressive Agents
;
Antipsychotic Agents
;
Autistic Disorder*
;
Behavioral Symptoms
;
Central Nervous System Stimulants
;
Child*
;
Drug Therapy
;
Drug Utilization
;
Female
;
Humans
;
Incidence
;
Insurance, Health*
;
International Classification of Diseases
;
Male
;
National Health Programs
;
Prescriptions*
;
Psychotropic Drugs
5.Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.
Ji Hyeong RYU ; Minsuk KWON ; Joung Dae MOON ; Min Woong HWANG ; Jeong Min LEE ; Ki Hyun PARK ; So Jeong YUN ; Hyun Jin BAE ; Aeran CHOI ; Hyeyoung LEE ; Bongsu JUNG ; Juhee JEONG ; Kyungja HAN ; Yonggoo KIM ; Eun Jee OH
Annals of Laboratory Medicine 2018;38(6):578-584
BACKGROUND: Accurate, rapid, and cost-effective screening tests for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection may be useful in laboratories that cannot afford automated chemiluminescent immunoassays (CLIAs). We evaluated the diagnostic performance of a novel rapid automated fluorescent lateral flow immunoassay (LFIA). METHODS: A fluorescent LFIA using a small bench-top fluorescence reader, Automated Fluorescent Immunoassay System (AFIAS; Boditech Med Inc., Chuncheon, Korea), was developed for qualitative detection of hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs), and antibody to HCV (anti-HCV) within 20 minutes. We compared the diagnostic performance of AFIAS with that of automated CLIAs—Elecsys (Roche Diagnostics GmbH, Penzberg, Germany) and ARCHITECT (Abbott Laboratories, Abbott Park, IL, USA)—using 20 seroconversion panels and 3,500 clinical serum samples. RESULTS: Evaluation with the seroconversion panels demonstrated that AFIAS had adequate sensitivity for HBsAg and anti-HCV detection. From the clinical samples, AFIAS sensitivity and specificity were 99.8% and 99.3% for the HBsAg test, 100.0% and 100.0% for the anti-HBs test, and 98.8% and 99.1% for the anti-HCV test, respectively. Its agreement rates with the Elecsys HBsAg, anti-HBs, and anti-HCV detection assays were 99.4%, 100.0%, and 99.0%, respectively. AFIAS detected all samples with HBsAg genotypes A-F and H and anti-HCV genotypes 1, 1a, 1b, 2a, 2b, 4, and 6. Cross-reactivity with other infections was not observed. CONCLUSIONS: The AFIAS HBsAg, anti-HBs, and anti-HCV tests demonstrated diagnostic performance equivalent to current automated CLIAs. AFIAS could be used for a large-scale HBV or HCV screening in low-resource laboratories or low-to middle-income areas.
Fluorescence
;
Gangwon-do
;
Genotype
;
Hepacivirus
;
Hepatitis B Surface Antigens*
;
Hepatitis B virus
;
Hepatitis B*
;
Hepatitis C*
;
Hepatitis*
;
Immunoassay*
;
Mass Screening
;
Sensitivity and Specificity
;
Seroconversion
6.Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
Hayne Cho PARK ; Juhee KIM ; AJin CHO ; Do Hyoung KIM ; Young-Ki LEE ; Hyunjin RYU ; Hyunsuk KIM ; Kook-Hwan OH ; Yun Kyu OH ; Young-Hwan HWANG ; Kyu-Beck LEE ; Soo Wan KIM ; Yeong Hoon KIM ; Joongyub LEE ; Curie AHN ;
Journal of Korean Medical Science 2020;35(22):e165-
Background:
Intrarenal renin-angiotensin system (RAS) is known to play the major role in the development of hypertension and renal progression in autosomal dominant polycystic kidney disease (ADPKD). Urinary angiotensinogen to creatinine ratio (AGT/Cr) was suggested as a novel biomarker to reflect intrarenal RAS activity. This study was performed to evaluate urinary AGT/Cr as a predictive biomarker for renal function decline in addition to imaging classification in a prospective ADPKD cohort.
Methods:
From 2011 to 2016, a total of 364 ADPKD patients were enrolled in the prospective cohort called the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). Among them, a total of 207 subjects in chronic kidney disease stage 1–4 with baseline urinary AGT and total kidney volume and subsequent renal function follow-up data over more than 1 year were included in the analysis. Patients were defined as slow progressors (SP) if they are classified as 1A or 1B by imaging classification whereas rapid progressors (RP) if they are classified as 1C–1E. Patients were divided according to AGT/Cr quartiles and annual estimated glomerular filtration rate (eGFR) slope was compared among highest quartile (hAGT group) and the rest of quartiles (lAGT group). Patients were divided into 4 groups to evaluate the predictive value of urinary AGT/Cr in addition to imaging classification: SP/lAGT, SP/hAGT, RP/lAGT, and RP/hAGT. The Cox regression model was used to evaluate the hazard ratio (HR) between groups.
Results:
The mean age was 45.9 years and 88.9% had hypertension. Baseline eGFR was 79.0 ± 28.4 mL/min/1.73 m2 and median height-adjusted total kidney volume was 788.2 (471.2;1,205.2) mL/m. The patients in the hAGT group showed lower eGFR (72.4 ± 24.8 vs. 81.1 ± 29.2 mL/min/1.73 m2, P = 0.039), lower plasma hemoglobin (13.0 ± 1.4 vs. 13.7 ± 1.6 g/dL, P = 0.007), higher urinary protein to creatinine ratio (0.14 [0.09, 0.38] vs. 0.07 [0.04, 0.12] g/g, P = 0.007) compared to the lAGT group. The hAGT group was an independent risk factor for faster eGFR decline after adjusting for gender, RP, baseline eGFR, and other known risk factors. During median follow-up duration of 4.6 years, a total of 29 renal events (14.0%) occurred. The SP/hAGT group showed significantly higher risk of developing renal outcome compared to SP/lAGT group (HR, 13.4; 95% confidence interval, 1.282–139.324; P = 0.03).
Conclusion
Urinary AGT/Cr can be a useful predictive marker in the patients with relatively small ADPKD. Various biomarkers should be considered to define RP when implementing novel treatment in the patients with ADPKD.